Altace and Atrioventricular block second degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block second degree is reported as a side effect among people who take Altace (ramipril), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Lipitor, and have Osteoporosis.

The phase IV clinical study analyzes which people have Atrioventricular block second degree when taking Altace. It is created by eHealthMe based on reports of 23,086 people who have side effects when taking Altace from the FDA, and is updated regularly.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

What is Atrioventricular block second degree?

Atrioventricular block second degree (heart block second degree) is found to be associated with 377 drugs and 818 conditions by eHealthMe. Check the latest studies of Atrioventricular block second degree.

On Jul, 11, 2026

23,086 people reported to have side effects when taking Altace.
Among them, 14 people (0.06%) have Atrioventricular block second degree.

Could Altace cause Atrioventricular block second degree?

Among these 14 people:

How long have people been on Altace when they have Atrioventricular block second degree? *

What is the gender of people who have Atrioventricular block second degree when taking Altace? *

female: 92.86 %
male: 7.14 %

What is the age of people who have Atrioventricular block second degree when taking Altace? *

What are other drugs people take besides Altace? *

What are other side effects people have besides Atrioventricular block second degree? *

Urinary Tract Infection: 10 people, 71.43%
Seborrhoeic Keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest): 9 people, 64.29%
Nodule (a growth of abnormal tissue): 9 people, 64.29%
Epidermal Necrosis (skin condition that is usually caused by a reaction to drugs): 9 people, 64.29%
Urination - Painful: 8 people, 57.14%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 8 people, 57.14%
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 8 people, 57.14%
Enterocele (hernia of the intestine through the vagina): 7 people, 50.00%
Fall: 7 people, 50.00%
Osteonecrosis Of Jaw (death of bone of jaw): 7 people, 50.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 8 people, 57.14%
Metastases To Bone (cancer spreads to bone): 2 people, 14.29%
Sleep Disorder: 1 person, 7.14%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.14%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Altace and have Atrioventricular block second degree?

- Check whether Atrioventricular block second degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Altace:

Altace (23,681 reports)

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (377 drugs)

Browse all the conditions that are associated with Atrioventricular block second degree:

Atrioventricular block second degree (818 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Altace) and Altace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.